Prosecutors claim Luigi Mangione's rage against health care industry led to CEO's murder
New York Gov. Kathy Hochul announced she would not remove New York City Mayor Eric Adams from office over federal corruption ...
Hosted on MSN2d
CVS Health Stock Gets RS Rating Upgrade
CVS Health stock received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73. Please watch the video ...
Why CVS Health (CVS) Is Among the Best Performing Healthcare Stocks So Far in 2025
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
CVS Health: One Good Quarter Is Not Enough; Retain Sell
Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...
CVS names new chief executive for Caremark PBM division
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...
CVS Health price target raised to $77 from $68 at Argus
Argus raised the firm’s price target on CVS Health (CVS) to $77 from $68 and keeps a Buy rating on the shares. Despite an uneven performance ...
Argus Research Sticks to Its Buy Rating for CVS Health (CVS)
In a report released on February 14, Steven Silver from Argus Research maintained a Buy rating on CVS Health (CVS – Research Report). The ...
Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?
Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted earnings for 2025 to land in a range between $5.75 and $6 per share. That's ...